ALPHA-DELTA-UA-[1->4]-GLCN
CAS123228-39-7
ALPHA-DELTA-UA-[1->4]-GLCN (CAS 123228-39-7, C12H19N1O10) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 123228-39-7
- Formula
- C12H19N1O10
- Mol. weight
- 337.28 g/mol
Chemical Specifications
Identifiers
| CAS number | 123228-39-7 |
|---|---|
| Product name | ALPHA-DELTA-UA-[1->4]-GLCN |
| Synonyms | ALPHA-DELTA-UA-[1->4]-GLCN; HEPARIN DISACCHARIDE IV-H; heparin disaccharide iv-H free acid; α-△ua-[1→4]-glcn; Heparin unsaturated disaccharide IV-H |
| Molecular formula | C12H19N1O10 |
| Molecular weight | 337.28 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Safety and transport
| Safety Statements | WGK Germany 3 |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of ALPHA-DELTA-UA-[1->4]-GLCN?
The CAS Registry Number of ALPHA-DELTA-UA-[1->4]-GLCN is 123228-39-7. ALPHA-DELTA-UA-[1->4]-GLCN is also known as ALPHA-DELTA-UA-[1->4]-GLCN; HEPARIN DISACCHARIDE IV-H; heparin disaccharide iv-H free acid.
What is the molecular formula and molecular weight of ALPHA-DELTA-UA-[1->4]-GLCN?
The molecular formula of ALPHA-DELTA-UA-[1->4]-GLCN is C12H19N1O10, and its molecular weight is 337.28 g/mol.
How can I request a quotation for ALPHA-DELTA-UA-[1->4]-GLCN?
Send an inquiry for ALPHA-DELTA-UA-[1->4]-GLCN (CAS 123228-39-7) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for ALPHA-DELTA-UA-[1->4]-GLCN
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.